openPR Logo
Press release

Neurological Biomarkers Market: Pipeline Overview 2017 - 2025

03-08-2018 09:23 AM CET | Health & Medicine

Press release from: Persistence Market Research

Neurological Biomarkers Market: Pipeline Overview 2017 - 2025

Biomarkers are biological markers which measure the biological states. It is used for indicating the normal biological and pathogenic process to a therapeutic intervention. These biomarkers can also be used in combination to access disease state of an individual. Scientists are exploring more about the structural and functional differences of the neurological diseases. Moreover, there has been an increase in biobanks which have help address unmet needs in oncology, neuroscience, and cardiovascular disease. 

The University of British Columbia and the Karolinska Institute in Sweden have set up biobanks that provide necessary resources and information for biomedical research. Alzheimer’s is the most common form of dementia affecting 12 million people. Neuroimaging and neuropsychological probes can help predict Alzheimer before behavioral tests diagnose. Thus pre-assessment tests such as Positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) are driving the demand for neurological biomarkers.

View Report Preview @ https://www.persistencemarketresearch.com/market-research/neurological-biomarkers-market.asp

The introduction of newer neurological biomarkers is expected to play a crucial role in helping neuropathologists in the characterization and selection of suitable treatment strategies. Moreover, with the advent of telehealth and personalized medicine, there is an emerging trend of single-cell biosensors as it may help integrating large-scale clinical and molecular information. 

These biomarkers are used in patients suffering from acute ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage and traumatic brain injury. Recovery from such neurocritical disease depends on how well the patient mitigates. In such situations, procurement of imaging studies or a good examination may be delayed due to the complexities involved. This shortcoming has further fueled the demand for biomarkers. The market is also experiencing recent trends with the researches undertaken on novel radiotracers, miRNA, and integration of systems biology into routine biomarker validation.

The neurological market is expected to witness growth owing to the various technological developments, the expansion in application and rise in the incidence of neurological disorders such as Alzheimer's, Parkinson’s and stroke. But the industry has certain restraints such as reproduction of positive trial results, the absence of pre-analytical tests and failure to investigate the efficiency of the biomarker as compared to previous one. 

Furthermore, the demand for these biomarkers is expected to propel as the demand for neurological care is increasing. In America, there are around 5.4 million people diagnosed with Alzheimer’s disease. The number is expected to triple to 16 million by 2050. The demand for procedural specialties is more as compared to on procedural specialties. This statement can be justified by the fact that the Medicare payment grew by 84% for procedural specialties and only 48% for non-procedural specialties. 

On the basis of imaging techniques the neurological biomarkers market can be segment as:

Transcranial magnetic stimulation (TMS)
Diffusion tensor imaging (DTI)
Conventional structural MRI (sMRI)
Functional magnetic resonance imaging (fMRI)
Positron emission tomography (PET) 

On the basis of application the neurological biomarkers market can be segment as:

Proteomics based biomarkers
Genomic based biomarkers
Imaging based biomarkers
Metabolic based biomarkers 

On the basis of indication the neurological biomarkers market can be segment as:

Alzheimer's disease (AD)
Multiple sclerosis (MS)
Parkinson's disease (PD)
Autism spectrum disorder (ASD)
 
On the basis of end-user the neurological biomarkers market can be segment as:

Hospitals
Clinics
Diagnostic and research laboratories 

On the basis of services the neurological biomarkers market can be segment as:

Sample preparation
Assay development
Biomarker validation and testing 

In terms of geography, the global neurological biomarkers market has been divided into five regions including North- America, Asia- Pacific and Middle-East & Africa, Latin America and Europe. North America has a major revenue share in the neurological biomarkers industry as many prominent market players are present in this region, the number of R&D projects carried out and the government funding received by academic universities to undertake research. For instance in August 2015, researchers, patients and various non-profit organizations participated in the Imaging Dementia -- Evidence for Amyloid Scanning (IDEAS) study. The USD 100 million project aims to study the utility of amyloid PET imaging to diagnose dementia, Alzheimer’s and cognitive impairment. 

Request to View TOC and Sample of Research Report @ https://www.persistencemarketresearch.com/samples/16303

Asia-Pacific is the fastest growing region as the region offers huge population base, high incidence rate of neurological abnormalities, entry of new market players and huge aging population. In developing economies such as India and China, new industry players are trying to establish their market presence by developing the generic version of the biomarker, through contract research organizations. This has further helped in reducing the manufacturing cost for the company and other production related cost. 

Key players in the neurological biomarkers industry are Myriad RBM, Proteome Sciences, QIAGEN, Thermo Fisher Scientific, AbaStar MDx, Acumen Pharmaceuticals, Abiant, Aepodia, Athena Diagnostics, ImmunArray, Quanterix and Cisbio Bioassays. 

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurological Biomarkers Market: Pipeline Overview 2017 - 2025 here

News-ID: 969569 • Views: 271

More Releases from Persistence Market Research

Adoption of Frozen Pastries Market to Soar Across Top Countries in the Globe
"Growing popularity of e-commerce and online retailing is expected to support the expansion of frozen pastries market globally. Moreover, frozen pastries offer the convenience of ready-to-eat pastry items in the comfort of home, which is further fueling their demand in the market." - Persistence Market Research. PMR examines the global frozen pastries market in its upcoming report titled, "Frozen pastries Market: Global Industry Analysis and Opportunity Assessment, 2016 - 2024". The
Increasing Consumer Awareness to Fuel Adoption of Tahini Market
Driven by growing popularity across the globe and steady adoption by the F&B industry, global tahini market volumes are estimated to surpass 314 thousand tonnes in 2016, up from nearly 305 thousand tonnes in 2015. According to the latest report published by Persistence Market Research titled "Global Market Study on Tahini: Paste and Spreads Product Type Segment Projected to Remain the Largest Segment During the Forecast Period," global volumes are
The Next Decade See Tea Market Pushed Towards Exponential Advancement
Persistence Market Research (PMR) delivers key insights on the global tea market in its published outlook titled, "Tea Market: Global Industry Analysis and Forecast, 2016-2024". In 2015, the global tea market was valued at US$ 13.85 Bn and is estimated to reach a value of US$ 14.45 Bn by the end of 2016, reflecting Y-o-Y growth rate of 4.0%. By 2024, the global tea market is expected to reach a
Inflatable Boat Market Sales to Top US$ 2.6 Bn by 2031|Key Players- Mercury Mari …
Inflatable Boat Market 2022 Inflatable Boats Market to Reach US$ 2.6 Bn by 2030; Sluggish Tourism Industry amidst COVID-19 Pandemic to Restrict Sales in Near Term. The global inflatable boats market is estimated to expand at a CAGR of 3.6% by value during the forecast period of 2020-2030. Request for Free Sample Copy of this Report@https://www.persistencemarketresearch.com/samples/18664 Rapidly growing demand from maritime security along with rising number of leisure activities are the main driving

All 5 Releases


More Releases for Alzheimer

Alzheimer Disease Drugs Market Global Trends, Market Share, Industry Size, Growt …
Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients suffering from Alzheimer’s disease is predicted to grow during the forecasting period. Alzheimer's treatment is a high risk, high reward market. Drugs currently
Anti-β-Alzheimer Therapies Market Analysis with Technological Advancement and G …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Alzheimer Diagnostic Tests Market GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as